Search

Displaying results 3411 - 3420 of 7059 in total
  1. Drug

    Zocainone

    go.drugbank.com/drugs/DB21326
    Experimental

    Zocainone has a monoisotopic molecular weight of 353.2 Da. … Zocainone is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Zocainone is a class I antiarrhythmic, procainamide and lidocaine derivative.

  2. Drug

    Atrimustine

    go.drugbank.com/drugs/DB21376
    Experimental

    Atrimustine has a monoisotopic molecular weight of 719.28 Da. … Atrimustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Atrimustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  3. Drug

    Pirenperone

    go.drugbank.com/drugs/DB21405
    Experimental

    Pirenperone has a monoisotopic molecular weight of 393.19 Da. … Pirenperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Pirenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  4. Drug

    Cinsebrutinib

    go.drugbank.com/drugs/DB21640
    Experimental

    Cinsebrutinib has a monoisotopic molecular weight of 383.2 Da. … Cinsebrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Cinsebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  5. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax has a monoisotopic molecular weight of 1038.41 Da. … Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  6. Drug

    Tocilizumab

    go.drugbank.com/drugs/DB06273
    ApprovedInvestigational

    [L44483] Tocilizumab-bavi, a biosimilar drug, was approved by the FDA in September 2023.[L48385]. … [A193281] Tocilizumab was granted FDA approval on 8 January 2010 to treat a number of inflammatory and autoimmune disorders, such as different types of arthritis and cytokine release syndrome.

  7. Drug

    Sedecamycin

    go.drugbank.com/drugs/DB21342
    Experimental

    Sedecamycin has a monoisotopic molecular weight of 501.24 Da. … Sedecamycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Sedecamycin is a antibiotic, produced by Streptomyces strain.

  8. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    Ambasilide has a monoisotopic molecular weight of 335.2 Da. … Ambasilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ambasilide is a sematilide derivative class III antiarrhythmic.

  9. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    Bitipazone has a monoisotopic molecular weight of 454.27 Da. … Bitipazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Bitipazone is a anti-inflammatory analgesic, phenylbutazone derivative.

  10. Drug

    Cianopramine

    go.drugbank.com/drugs/DB19470
    Experimental

    Cianopramine has a monoisotopic molecular weight of 305.19 Da. … Cianopramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Cianopramine is a substance of the imipramine group.